Central nervous system depression, vital signs, and electrocardiograms require monitoring in symptomatic patients. Fluids and electrolytes should be monitored in patients with prolonged vomiting as well.

Patients on bromocriptine should be tested for pregnancy every four weeks during amenorrhea or if the menstrual period is late by more than three days. Complete blood counts with differential, liver function test, BUN/Cr, and cardiovascular evaluation should take place.

Patients on pramipexole should receive monitoring for baseline creatinine levels, orthostatic hypotension, and skin reactions.

When taking ropinirole, the patient should monitor skin reactions and orthostatic hypotension, especially during dose titration.